Medical News

RSS

Vectorious Medical Technologies closes $5 million financing round

Vectorious Medical Technologies, an Israeli company developing a novel cardiac monitoring system for patients suffering from congestive heart failure (CHF), announced today that it has closed a $5 million financing round.

26 Feb 2015

Deadly C. difficile affected almost half a million in the U.S over one year

The deadly bug Clostridium difficile (C. diff) infected more than 450,000 people in the U.S in a single year, according to new research funded by the Centers for Disease Control and Prevention (CDC).

26 Feb 2015

ABIVAX doses first patient in ABX203 Phase IIb/III trial for treatment of chronic hepatitis B

ABIVAX, a clinical stage biotech company developing and commercialising anti-viral compounds and human vaccines, today announced that it has dosed in New Zealand the first patient in a Phase IIb/III clinical trial of ABX203 which is taking place in several countries of the Asia-Pacific region.

26 Feb 2015

Regeneron announces EU approval of EYLEA (aflibercept) Injection for retinal vascular disease treatment

Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Macular Edema secondary to Retinal Vein Occlusion (RVO).

26 Feb 2015

Lyric announces initial closing of $20.4 million Series A financing round

Lyric Pharmaceuticals Inc. today announced the initial closing of a Series A financing round totaling $20.4 million. The financing, co-led by RiverVest Venture Partners, Sante Ventures and Third Point Ventures, includes participation by Aperture Venture Partners.

26 Feb 2015

Noble Hospital surgeon to present work on new breast cancer device at Miami Breast Cancer Conference

A Noble Hospital breast surgeon's work with a new device that improves treatment of breast cancers will be featured later this month at a prestigious international medical conference.

26 Feb 2015

HeartWare International's revenue increases 38% to $73.2 million in Q4 2014

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $73.2 million for the fourth quarter ended December 31, 2014, a 38% increase compared to $53.1 million in revenue for the same period of 2013. For the fiscal year 2014, the company generated revenue of $278.4 million, a 34% increase compared to revenue of $207.9 million in 2013.

26 Feb 2015

Cipher acquires worldwide rights to three products from Astion

Cipher Pharmaceuticals Inc. today announced it has strengthened its product pipeline by acquiring the worldwide rights to three products from Astion Pharma, a Denmark-based specialty pharmaceutical company.

26 Feb 2015

MiMedx Group reports record revenue of $118.2 million for full year 2014

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the fourth quarter and full year ended December 31, 2014.

26 Feb 2015

Bruker-sponsored sixth AFM Biomed conference highlights increasing impact of AFM in biological applications

Bruker recently sponsored the sixth AFM BioMed International Meeting on AFM in Life Sciences and NanoMedicine. Held last month at the Sanford Consortium for Regenerative Medicine in La Jolla, CA, the conference brought together more than 125 scientists from around the world.

From Bruker Nano Surfaces and Metrology 26 Feb 2015

Patients with Parkinson's disease often face difficulties with reduced visual contrast acuity

Patients with Parkinson's disease (PD) often have difficulties with visual acuity in low-contrast images. Because they may have normal high-contrast vision, this is often overlooked during routine eye exams. In the current issue of the Journal of Parkinson's Disease, researchers report that PD patients had significantly worse vision for low-contrast images at close (40 cm) and far (2 m) distances. Even for high-contrast images, PD patients' vision was deficient at far distances.

26 Feb 2015

Predicting the development of type 1 diabetes is possible, shows TEDDY study

New research shows that it is possible to predict the development of type 1 diabetes. By measuring the presence of autoantibodies in the blood, it is possible to detect whether the immune system has begun to break down the body's own insulin cells.

26 Feb 2015

Study may give health workers vital new evidence in fight against Ebola

One year after the first Ebola cases started to surface in Guinea, the latest findings from a Cochrane review show new ways of hydrating patients in critical care environments across the world.

26 Feb 2015

Emulsifiers can alter gut microbiota composition to induce intestinal inflammation

Emulsifiers, which are added to most processed foods to aid texture and extend shelf life, can alter the gut microbiota composition and localization to induce intestinal inflammation that promotes the development of inflammatory bowel disease and metabolic syndrome, new research shows.

26 Feb 2015

UMass Amherst biologist partners with Chinese scientist to develop novel drug platform

Margaret Riley, an evolutionary biologist at the University of Massachusetts Amherst and pioneer in fighting antibiotic-resistant bacteria, announced this week that she is partnering with a Chinese scientist to develop a new drug platform, pheromonicins. The Chinese government is committing $400 million per year to support the newly created Pheromonicin Institute of Beijing.

26 Feb 2015

Unique research consortium focuses on musculoskeletal disorders and diseases

The Kansas City University of Medicine and Biosciences, the University of Missouri – Kansas City and the University of Kansas Medical Center proudly announce a research consortium among the three Kansas City-area institutions. The consortium brings together scientists and resources focused on the research of musculoskeletal disorders and diseases.

26 Feb 2015

Study reveals causes of community-acquired pneumonia in children

With the chill of winter comes a spike in community-acquired pneumonia (CAP), which spreads more easily as people retreat indoors and come into close contact. The lung infection triggers persistent coughing, chest pain, fever, and difficulty breathing, and is particularly hard on the very young and the very old. In fact, pneumonia is the leading cause of hospitalization among U.S. children, with estimated medical costs of $1 billion annually.

26 Feb 2015

RowanSOM researcher awarded NINDS grant to develop stem cell-based therapy for Canavan disease

Paola Leone, PhD, the director of the Cell and Gene Therapy Center and a professor of Cell Biology at the Rowan University School of Osteopathic Medicine, has been awarded a three-year, $477,000 grant from the National Institute of Neurological Disorders and Stroke to develop a stem cell-based therapy for Canavan disease, a rare but devastating neurological disorder in children that typically takes a child's life by age 10.

26 Feb 2015

Sleeping more than eight hours a night could increase risk of stroke

People who sleep more than eight hours a night may have an increased risk of stroke, according to a new study published in the February 25, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

26 Feb 2015

Preliminary NIBIB-funded study may improve prediction of mild traumatic brain injury

A preliminary study conducted by researchers funded by the National Institute of Biomedical Imaging and Bioengineering may improve our prediction of mild traumatic brain injury (mTBI). Every year more than 40 million people worldwide suffer from mTBI. 3.8 million concussions occur in the US each year during sports and recreation alone.

26 Feb 2015

Medical News

Vectorious Medical Technologies closes $5 million financing round

Deadly C. difficile affected almost half a million in the U.S over one year

ABIVAX doses first patient in ABX203 Phase IIb/III trial for treatment of chronic hepatitis B

Regeneron announces EU approval of EYLEA (aflibercept) Injection for retinal vascular disease treatment

Lyric announces initial closing of $20.4 million Series A financing round

Noble Hospital surgeon to present work on new breast cancer device at Miami Breast Cancer Conference

HeartWare International's revenue increases 38% to $73.2 million in Q4 2014

Cipher acquires worldwide rights to three products from Astion

MiMedx Group reports record revenue of $118.2 million for full year 2014

Bruker-sponsored sixth AFM Biomed conference highlights increasing impact of AFM in biological applications

Patients with Parkinson's disease often face difficulties with reduced visual contrast acuity

Predicting the development of type 1 diabetes is possible, shows TEDDY study

Study may give health workers vital new evidence in fight against Ebola

Emulsifiers can alter gut microbiota composition to induce intestinal inflammation

UMass Amherst biologist partners with Chinese scientist to develop novel drug platform

Unique research consortium focuses on musculoskeletal disorders and diseases

Study reveals causes of community-acquired pneumonia in children

RowanSOM researcher awarded NINDS grant to develop stem cell-based therapy for Canavan disease

Sleeping more than eight hours a night could increase risk of stroke

Preliminary NIBIB-funded study may improve prediction of mild traumatic brain injury

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News